SMARTGNOSTICS
Mobilising Agendas/Alliances for Reindustrialisation - Application No. 5
The SMARTgNOSTICS project aims to develop innovative POC devices for the global monitoring of antibiotic-resistant pathogens, as well as antibiotics and residues themselves. The devices to be developed in this project would represent an important step in the fight against AMR, providing a basis for international action, implementation of mitigation strategies and evaluation of progress achieved. Thus, this project covers the 4 pillars of the AMR cycle: Human Health, Animal Health, Environment and Food Safety.
ALS LIFE SCIENCES PORTUGAL, S.A.
INSTITUTO NACIONAL DE INVESTIGAÇÃO AGRÁRIA E VETERINÁRIA, I.P.
LABORATÓRIO IBÉRICO INTERNACIONAL DE NANOTECNOLOGIA (LIN)
UNIVERSIDADE DO MINHO
INESC TEC - INSTITUTO DE ENGENHARIA DE SISTEMAS E COMPUTADORES, TECNOLOGIA E CIÊNCIA
INEGI - INSTITUTO DE CIÊNCIA E INOVAÇÃO EM ENGENHARIA MECÂNICA E ENGENHARIA INDUSTRIAL
INSTITUTO NACIONAL DE SAÚDE DR. RICARDO JORGE, I.P.
INSTITUTO DE SAÚDE PÚBLICA DA UNIVERSIDADE DO PORTO
SPMAQ-SOLUÇÕES PROJECTOS MAQUINAS UNIPESSOAL LDA
FRESENIUS KABI PHARMA PORTUGAL LDA
ASSOCIAÇÃO UNIVERSIDADE-EMPRESA PARA O DESENVOLVIMENTO-TECMINHO
20/07/2022
01/01/2023
31/12/2025
EUR 20,924,584.02
EUR 15,647,204.01
Antibiotic resistance (AMR) represents a significant global threat of vast proportions. It is estimated that drug-resistant infections cause around 5 million deaths every year. In the European Union, more than 33,000 people die from AMR each year, with an economic impact of approximately €1.5 billion/year in healthcare costs and lost productivity. The WHO has declared AMR as one of the top 10 global public health threats and has requested that all countries implement national action plans to prevent the indiscriminate use of antibiotics. It is therefore a serious public health crisis affecting global economies. WHO estimates that if no action is taken, the number of deaths is expected to rise to 10 million per year by 2050, overtaking diabetes, heart disease and cancer as the leading cause of death.
Antibiotic resistance (AMR) is a complex process that occurs when bacteria adapt to the continued presence of antibiotics, resulting in new bacterial strains that no longer respond to antibiotic treatments. This makes infections virtually untreatable, increasing the risk of disease spread, serious illness and death.
The SMARTgNOSTICS project proposes a holistic "One Health" approach to the AMR problem, by developing devices/solutions to tackle bacteria, AMR genes and antibiotic residues in several fields that make up the AMR cycle: human and animal health, food safety and the environment. The aim is to develop point-of-care (POC) solutions that can be simultaneously "lab-on-a-chip" coupled with data acquisition and processing through Artificial Intelligence (AI), providing integrated data for predictive analysis of future AMR genes and/or pathogens. This will provide an Early Warning System to control/monitor/prevent a future "superbug" pandemic.
Photovoltaic system for self-consumption 90470Wp
Support for the Decarbonization of Industry (Modality A)
The 90470Wp Photovoltaic System for Self-Consumption project aims to implement a photovoltaic system for self-consumption in order to significantly reduce energy consumption from the public grid in production activities and make the company more sustainable and energy efficient. It promotes the reduction of greenhouse gas emissions.
SPMAQ-SOLUÇÕES PROJECTOS MÁQUINAS UNIPESSOAL LDA
15/03/2023
23/01/2023
31/12/2023
72,007.25 euros
61,206.16 euros